Page 205 - HIVMED_v21_i1.indb
P. 205

Page 11 of 15  Original Research




                                 %         0  0  0  10  90    0  0  0  100     0  0  0  100     0  0  0  100
                               96 h   161 ± 68  81–269  112 ± 34  68–166  136 ± 41  82–201  137 ± 57  83–324
                                 n         0   0   0   2   19   0   0   0   21   0   0   0   21  0   0   0   21



                                 %         0  0  0  9  91     0  0  4.5  95.5  0  0  4.5  -     0  0  0  100
                             i-STAT  24 h  152 ± 56  62–269  107 ± 27  55–166  130 ± 32  66–209  130 ± 51  76–324

                                 n         0   0   0   2   20   0   0  1  21   0   0   1   21   0   0   0    22



                                 %         0  0  0  9  91     0  0  4.5  95.5  0  0  0  100     0  0  0  100
                                      147 ± 50          104 ± 126
                               4 h       63–269             55–166       125 ± 32  67–200  125 ± 52  78–328
                                 n         0   0   0   2   20   0   0   1   21  0   0   0   22   0   0   0   22


                          TABLE 3: Chronic Kidney Disease staging using the four equations based on creatinine results obtained from the enzymatic, kinetic Jaffe and i-STAT methods.
                                 %         5.5  50  39  5.5  0  0  22  67  11  5.5  5.5  39  0  0  0  11  89
                               96 h   45 ± 10  24–63    51 ± 9  31–67    42 ± 7  26–55    79 ± 28  47–162

                                 n         1  9   7   1  0    0   4   12   2   1   10   7   0   0   0   2   16


                                 %         0  9  27  45  18   0  0  14  86     0  0  9  8       0  0  4.5  95.5
                             Kinetic Jaffe  24 h  n  75± 33  34–181  0   2   6   10   4   83 ± 31  55–190  0   0   3   19   69 ± 26  45–157  0   0   11   11   111 ± 69  54–391  0   0   1   21





                                 %         0  0  0.5  32  64  0  0  4.5  95.5  0  0  0  100     0  0  0  100

                               4 h    100 ± 26  48–150  91 ± 18  52–125  100 ± 22  63–151  129 ± 54  69–333
                                 n         0   0   1   7   14   0   0   1   21   0   0   0   22   0   0   0   22



                                 %         0  0  0  31  69    0  0  0  100     0  0  0  100     0  0  0  100
                               96 h   114 ± 28  73–148  89 ± 15  62–108  108 ± 18  75–133  125 ± 51  79–295
                                 n         0   0   0   5   11   0   0   0   16   0   0   0   16   0   0   0   16



                                 %         0  0  4.5  18  77  0  0  9  91      0  0  9  91      0  0  0  100 CKD-EPI, Chronic Kidney Disease-Epidemiology; eGFR, estimated glomerular filtration rate; MDRD, Modifications of Diet in Renal Disease; CG, Cockcroft-Gault.
                             Enzymatic  24 h  n  118 ± 37  53–210  0   0  1  4   17   89 ± 21  40–137  0   0   2   20   108 ± 26  59–166  0   0  2   20   128 ± 64  66–382  0   0   0   22






                                 %         0  0  4.5  23  73  0  0  4.5  95.5  0  0  4.5  95.5  0  0  0  100
                               4 h    118 ± 36  53–217  89 ± 20  49–141  108 ± 25  59–171  129 ± 66  66–391
                                 n         0   0   1   5   16   0   0   1   21   0   0   1   21   0   0   0   22






                             Measure  CKD-EPI  eGFR mean   (mL/min per 1.73 m²)  Range   15–29  30–44  45–59  60–89  ≥ 90   MDRDv3  eGFR mean   (mL/min per 1.73 m²)  Range   15–29  30–44  45–59  > 60  MDRDv4   eGFR mean   (mL/min per 1.73 m²)  Range   15–29   30–44  45–59  > 60  CG   eGFR mean   (mL/min per 1.73 m²)  Range  15–29  30–44  45–59  > 60



                                           http://www.sajhivmed.org.za 197  Open Access
   200   201   202   203   204   205   206   207   208   209   210